oncology

1,857 projects

HEIndividual fellowship2026–2028Austria

WAIXYN · Component-based synthesis of Waixenicin A enables TRPM7 inhibitor development

HEIndividual fellowship2026–2028Belgium

RasWayToALL · Role of RAS mutant subclones in the development of High Hyperdiploid B-ALL

HEStaff exchange2026–2029Netherlands

LIGHTHER · First-in-kind anticancer therapy combining light-controllable cytotoxic peptides and dendritic cell-based immunotherapy

6 partners · 3 countries

HEStaff exchange2026–2029Spain

TUMORGPLAT · Making patient-derived tumor organoids a reliable cancer therapy testing platform

6 partners · 3 countries

HEDoctoral network2026–2030Netherlands

LipidBRIGHT · Lipids as promising BRidge between novel disease InsiGHts and improved Therapy

25 partners · 6 countries

HEIndividual fellowship2026–2028Belgium

ReTenTion · Next Generation Immune Checkpoint Inhibitor for Cancer Therapy

2 partners

HEDoctoral network2026–2029Netherlands

HER-CARE · Hereditary and Early onset breast cancer: Comprehensive personalized Assessment, early Risk Evaluation, and clinical management

33 partners · 13 countries

HEDoctoral network2026–2029United Kingdom

ON-TRACT · OligoNucleotide Technologies for Rapid Advancement of Cancer Therapies

16 partners · 6 countries

HEDoctoral network2026–2029Germany

RAPTORplus · Right-time Adaptive Particle Therapy Of canceR - Personalisation through anatomical plus biological adaptation

34 partners · 13 countries

HEIndividual fellowship2026–2028United Kingdom

hNanoBio · Heterostructure Nano-photoelectronic Biosensor for Single Molecule Detection

4 partners · 3 countries

HEIndividual fellowship2026–2027Germany

PROTONIX · Bridging protein structure prediction with molecular simulations via diffusion models for missing protonation states

2 partners · 2 countries

HEIndividual fellowship2026–2027Hungary

DNACopyComp · Development of a predictive quantum simulation protocol for understanding DNA polymerase function and toxic inhibition

HEIndividual fellowship2026–2030Italy

RESPIRE · Artificial intelligence enabled electrospinning approach to fight pulmonary cancer

4 partners · 2 countries

HEIndividual fellowship2026–2028Portugal

URC-Hypoxia · Unlocking the Redox Code: Mapping the Molecular Mechanisms of Hypoxia Tolerance

HEIndividual fellowship2026–2028United Kingdom

ModProtease · Design of ModProtease through High-Throughput Screening Technologies for Therapeutic Applications

HEIndividual fellowship2026–2029Italy

MITO · Scalable real-time monitoring of 3D cell cultures with electrical impedance microtomography

2 partners · 2 countries

HEIndividual fellowship2026–2029Italy

SYNOPSIS · SYNergic multimodal platform for high-throughput anti-cancer bOne-metastases theraPy ScreenIngS

2 partners · 2 countries

HEIndividual fellowship2026–2028Sweden

SPARC · Spatial profiling of gastric cancer with peritoneal carcinomatosis to tackle cancer spreading and improve precision immuno-oncology

2 partners · 2 countries

HEIndividual fellowship2026–2028France

ICONES · Ion-ion COllisioN Electron Spectroscopy

HEIndividual fellowship2026–2028Netherlands

T-REaCT · Evolution of T cell reactivity against somatic mutations across human colon cancer stages with single-cell genomics and synthetic T cell specificity screening

3 partners · 2 countries

HEIndividual fellowship2026–2028Spain

MechanoSecret · Exploring the Mechanobiology of the Secretory pathway across scales

HEIndividual fellowship2026–2028United Kingdom

syRNAlb · Human serum albumin nanoparticles for synergistic chemotherapy and oligonucleotide therapy against oncogenic lncRNAs in lung cancer

HEIndividual fellowship2026–2028Czechia

Nano-LYTAC · Nanotherapeutic platform for lysosomal targeted technology

2 partners

HEIndividual fellowship2026–2028United Kingdom

NatK · Harnessing natural killer cells to combat chemotherapy resistance